TARGOSAFE 200 INJECTION

Product Description

Product Name: TARGOSAFE 200 INJECTION
Composition: Teicoplanin 200mg
Category: Antibiotic Injection | Glycopeptide Antibiotic | Hospital Supplies

SEO-Optimized Product Description for Trade India & B2B Platforms:

TARGOSAFE 200 INJECTION contains Teicoplanin 200mg, a powerful glycopeptide antibiotic used for the treatment of serious gram-positive bacterial infections, including MRSA, bone and joint infections, skin and soft tissue infections, respiratory tract infections, and septicemia. Known for its broad-spectrum activity, long half-life, and excellent tissue penetration, TARGOSAFE is a preferred choice in critical care settings.

Manufactured under WHO-GMP certified facilities, TARGOSAFE 200 INJECTION is trusted by hospital pharmacies, ICUs, and healthcare institutions for its clinical reliability and pharmaceutical-grade quality.

Key Benefits:

• Teicoplanin 200mg: Effective against resistant gram-positive infections (including MRSA)

• Suitable for severe systemic infections and hospital-acquired infections

• Administered via intravenous (IV) or intramuscular (IM) injection

• Long-acting formulation enables once-daily dosing

• Well-tolerated alternative to vancomycin with lower nephrotoxicity risk

• Ideal for use in ICU, surgical wards, and post-operative infection control

Product Specifications:

• Dosage Form: Injectable

• Strength: 200mg Teicoplanin per vial

• Packaging: Glass vial with sterile water for injection

• Shelf Life: 24 months

• Storage: Store below 25C in a dry place; protect from light

Target Buyers:

• Pharmaceutical distributors and bulk drug suppliers

• Hospitals, nursing homes, and critical care units

• Retail pharmacies and institutional buyers

• Exporters and government healthcare tenders

For Business Inquiries:
Contact us for bulk purchase orders, hospital supply contracts, P2P manufacturing, and export partnerships. We ensure regulated quality, competitive pricing, and prompt delivery for domestic and international markets.